We are reimagining the way the world makes and supplies medicines so patients everywhere
- can get the medicines they need
- in the way that’s best for them
- at a price that their health service can afford.
The REMEDIES (RE-configuring MEDIcines End-to-end Supply) Project is headed up by GlaxoSmithKline with research led by the University of Cambridge’s Institute for Manufacturing.
REMEDIES is a broad-based collaboration examining how the multi-billion pound global medicines manufacture and supply sector, from patent to patient, can be reshaped to meet the needs, expectations and budgets of the world we serve.
Photo courtesy of GSK